Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Open-Label Abatacept Safety Study in Rheumatoid Arthritis
2004-005102-68Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2005
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started May 2005; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2004-005102-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005102-68.